@@include("_head.html") 
@@include("_header.html")

<main class="main">
	<!-- <div class="main__breadcrumbs container">
		<div class="breadcrumbs">
			<a class="breadcrumbs__item" href="./">Home</a>
			<span class="breadcrumbs__item breadcrumbs__item_current">Process Development</span>
		</div>
	</div> -->

	<section class="p-layout container">
		<div class="p-layout__section">
			<div class="p-layout__side">
				<div class="t-block">
					<h1 class="t-block__title title">Process Development</h1>
					<div class="t-block__text t-block__text_large">
						<p>The importance of strategic process development (PD) as a program advances cannot be overstated. It is critical to increasing yields, achieving product quality expectations, and lowering the cost of goods (COGS) while meeting clinical development milestones.</p>
						<p>The Center for Breakthrough Medicines (CBM) has a Process Development team with unrivaled experience building and optimizing processes for commercial gene and cell therapies.</p>
					</div>
				</div>
			</div>
			<div class="p-layout__image p-layout__image_up p-layout__image_decor-3 t-image">
				<img src="./images/stuff/content-image-10.png" alt="">
			</div>
		</div>
	</section>

	<section class="m-strategy container">
		<h2 class="m-strategy__title title">Strategic development drives flawless GMP execution</h2>
		<div class="m-strategy__image t-image"><img src="./images/stuff/content-image-12.png" alt=""></div>
		<div class="m-strategy__items">
			<div class="m-strategy__item">
				<h3 class="m-strategy__subtitle title title_subtitle">Developing Strategy</h3>
				<div class="m-strategy__text">CBM begins with a knowledge transfer of your existing process, or the development of a de novo custom bioprocess from scratch. Our PD team then develops an optimal product strategy to align processes and equipment with future pilot scale and cGMP-scale operations.</div>
			</div>
			<div class="m-strategy__item">
				<h3 class="m-strategy__subtitle title title_subtitle">Implementing Strategy</h3>
				<div class="m-strategy__text">Our viral vector process solutions are fully scalable. All upstream processes are designed to meet safety, quality, and yield expectations and are scalable to phase-appropriate production volumes while maintaining critical quality attributes (CQAs) throughout the product lifecycle to commercialization.</div>
			</div>
			<div class="m-strategy__item">
				<h3 class="m-strategy__subtitle title title_subtitle">Technology Transfer</h3>
				<div class="m-strategy__text">Our PD and cGMP manufacturing teams closely collaborate and are cross-trained to ensure process performance and quality. CBM’s pilot plant operations support scale-up, scale-out, preclinical production, tech transfer, cGMP readiness, and training. From here, we seamlessly transfer your manufacturing process and scale up with pilot and training runs in one location to advance your project to cGMP production.</div>
				<a class="m-strategy__link" href="./">Learn about CBM’s Analytical Development & Testing ></a>
			</div>
		</div>
	</section>

	<section class="m-process m-process_light">
		<div class="container">
			<h2 class="m-process__title title">Viral Vector Process Development</h2>
			<div class="m-process__items">
				<div class="m-process__item">
					<h3 class="m-process__subtitle title title_subtitle">Upstream</h3>
					<ul class="m-process__list">
						<li>Suspension and adherent manufacturing platforms for Adeno-Associated Virus (AAV), Adenovirus, Lentivirus, and other novel viral vectors</li>
						<li>Research cell and virus banking (RCB & RVB)</li>
						<li>Process development, optimization, and characterization</li>
						<li>Process validation / BLA-enabling activities</li>
						<li>Pilot production to support IND-enabling studies</li>
					</ul>
				</div>
				<div class="m-process__item">
					<h3 class="m-process__subtitle title title_subtitle">Downstream</h3>
					<ul class="m-process__list">
						<li>Viral vector purification capabilities across all processing steps: filtration, chromatography, and ultracentrifugation</li>
						<li>Process development, optimization, and characterization </li>
						<li>Process validation / BLA-enabling activities</li>
						<li>Pilot production to support IND-enabling studies</li>
					</ul>
				</div>
				<div class="m-process__item">
					<h3 class="m-process__subtitle title title_subtitle">Drug Product & Analytics</h3>
					<ul class="m-process__list">
						<li>High-throughput formulation development</li>
						<li>Drug product process development and characterization</li>
						<li>Stability and force-degradation studies</li>
					</ul>
				</div>
				<div class="m-process__item m-process__item_notitle">
					<ul class="m-process__list">
						<li>Pilot-scale drug product filling to enable tech transfer and support IND-enabling studies</li>
						<li>In-use stability and device compatibility studies</li>
					</ul>
				</div>
			</div>
			<a class="m-process__link" href="./">Learn about CBM’s Viral Vector Capabilities ></a>
		</div>
	</section>

	<section class="m-process m-process_decor-1">
		<div class="container">
			<h2 class="m-process__title title">Cell Therapy Process Development</h2>
			<div class="m-process__items">
				<div class="m-process__item">
					<h3 class="m-process__subtitle title title_subtitle">Drug Substance</h3>
					<ul class="m-process__list">
						<li>Process development and characterization for both autologous and allogenic products</li>
						<li>Process validation / BLA-enabling activities</li>
						<li>Pilot production to support IND-enabling studies</li>
						<li>Technology transfer / GMP readiness</li>
					</ul>
				</div>
				<div class="m-process__item">
					<h3 class="m-process__subtitle title title_subtitle">Drug Product</h3>
					<ul class="m-process__list">
						<li>Formulation development</li>
						<li>Formulation & fill process automation and closure</li>
						<li>Cryopreservation cycle development</li>
						<li>Container closure development</li>
						<li>In-use stability and device compatibility studies</li>
					</ul>
				</div>
			</div>
			<a class="m-process__link" href="./">Learn about CBM’s Viral Vector Capabilities ></a>
		</div>
	</section>

	<section class="m-subscribe">
		<div class="m-subscribe__inner container">
			<form class="m-subscribe__form m-form" action="./">
				<h2 class="m-subscribe__title title title_subtitle">Learn how CBM can integrate your Plasmid DNA and Cell Therapy programs</h2>
				<div class="m-form__field"><input type="text" name="fname" placeholder="First Name:"></div>
				<div class="m-form__field"><input type="text" name="lname" placeholder="Last Name:"></div>
				<div class="m-form__field"><input type="text" name="email" placeholder="Email:"></div>
				<div class="m-form__field"><input type="text" name="company" placeholder="Company:"></div>
				<button class="m-form__submit button button_white" type="submit">Connect ></button>
			</form>
			<div class="m-subscribe__side">
				<div class="m-subscribe__side-block">
					<h3>Viral Vectors</h3>
					<p>CBM’s viral vector platform efficiently and consistently delivers high yields in AAV, Lentivirus, HSV and Adenovirus vectors, accelerating the development of new therapies.</p>
				</div>
				<div class="m-subscribe__side-block">
					<h3>Cell Therapy Manufacturing</h3>
					<p>CBM has one of the cell therapy’s most experienced teams and the largest single site facility in the industry. There is no greater centralization of expertise.</p>
				</div>
				<div class="m-subscribe__side-block">
					<h3>Our Experienced Team</h3>
					<p>Our team brings a wealth of experience from biopharma and advanced therapy CDMOs, ensuring that there is no safer place for your product.</p>
				</div>
			</div>
		</div>
	</section>

</main>

@@include("_bottom.html")